Brief: Xbrane Biopharma: Product Portfolio Update With New Full Strategic Focus On Biosimilars
10/09/2018 07:09
Sept 10 (Reuters) - Xbrane Biopharma AB XBRANE.ST :
* REG-XBRANE BIOPHARMA ANNOUNCES PRODUCT PORTFOLIO UPDATE
WITH A
NEW FULL STRATEGIC FOCUS ON BIOSIMILARS
* WILL INITIATE DEVELOPMENT OF TWO ADDITIONAL BIOSIMILARS ON
BIOLOGICS WITH PATENT EXPIRATION 2026-2028
Source text for Eikon: ID:nGNEvWgky
Further company coverage: XBRANE.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))